Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine and TEAS for Postoperative Recovery in Cesarean Section
NCT07916051Not yet recruiting
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Oct 2026
- Primary completion
- Oct 2027
01
Overview
Randomised, double-blind trial of esketamine in postoperative pain (4 arms), sponsored by The First Affiliated Hospital of USTC. Primary endpoint: Quality of Postoperative Recovery at 3 days. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07916051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07916051.